Lifetech CeraFlex™ Post-Market Surveillance Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02621528
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT02621528
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany, Ireland, Italy, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02621528. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (actual); primary completion 2019-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lifetech CeraFlex™ Post-Market Surveillance Study
- Condition
- Patent Foramen Ovale
- Condition
- Atrial Septal Defect
- Condition
- Patent Ductus Arteriosus
- Intervention (Device)
- CeraFlex
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct02621528- Content hash
ad8611730ad16c6fc945f49a13912fadfdbfc9b6230cbdd08a1f5ce494028a8a